Published Mr. Thanawat Suwatthanarak. PhD, a researcher from Siriraj Cancer Center, attended the international conference ESMO Targeted Anticancer Therapies Congress 2025 held between March 3rd – 5th, 2025, in Paris, France, to present a research poster titled “Tetraspanins CD37 and CD53: Immune Modulators in Stage IV Colorectal Cancer—A Single-Cell Spatial Transcriptomic Study for Targeted Therapeutic Insights”.
The ESMO Targeted Anticancer Therapies (TAT) Congress 2025 focuses on early-phase clinical trials and new drug development in oncology, often referred to as the “home of phase I in oncology.”
